Journals / Türk Osteoporoz Dergisi / 2019 / Cilt: 25 - Sayı: 3

Prevalence and Risk Factors of Osteoporosis in Men with Chronic Obstructive Pulmonary Disease in Kars Province

Kars İlinde Kronik Obstruktif Akciğer Hastalığı Olan Erkeklerde Osteoporoz Sıklığı ve Risk Faktörleri

Pages
99–104
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient’s age, smoking duration,COPD stage, and use of steroid history was significantly associated with osteoporosis (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality today.
📊
Key Findings & Data:This study aimed to evaluate the prevalence and risk factors of osteoporosis in men with COPDin Kars province.Materials and Methods: In this retrospective study performed on 88 male patients diagnosed with COPD, demographic data of the patientswere recorded.
💡
Conclusion & Impact:The patient’s age, smoking duration,COPD stage, and use of steroid history was significantly associated with osteoporosis (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality today. Osteoporosis is known tobe seen more commonly in COPD patients. This study aimed to evaluate the prevalence and risk factors of osteoporosis in men with COPDin Kars province.Materials and Methods: In this retrospective study performed on 88 male patients diagnosed with COPD, demographic data of the patientswere recorded. The histories that duration of smoking and the use of steroid were documented. Pulmonary function tests and bone mineraldensities were analyzed from their files.Results: The prevalence of osteopenia and osteoporosis in our study was 46.5% and 50%, respectively. The patient’s age, smoking duration,COPD stage, and use of steroid history was significantly associated with osteoporosis (p

Özet

Amaç: Kronik obstrüktif akciğer hastalığı (KOAH), günümüzde önemli bir morbidite ve mortalite nedenidir. KOAH’li hastalarda osteoporozun daha sık görüldüğü bilinmektedir. Bu çalışma, Kars ilindeki KOAH’li erkeklerde osteoporoz prevalansını ve risk faktörlerini değerlendirmeyi amaçlamıştır. Gereç ve Yöntem: KOAH tanısı olan 88 erkek hasta üzerinde retrospektif olarak yapılan çalışmada hastaların demografik verileri kaydedildi. Sigara kullanım süresi, steroid kullanım öyküleri dokümante edildi. Solunum fonksiyon testleri ve kemik mineral yoğunlukları dosyalarından analiz edildi. Bulgular: Çalışmamızda osteopeni ve osteoporoz prevalansı sırasıyla %46,5 ve %50 idi. Hastanın yaşı, sigara kullanım süresi, KOAH evresi, steroid kullanım öyküsü osteoporoz ile anlamlı olarak ilişkiliydi (p

🔖

Cite This Article

BAĞCIER, F., PERİNÇEK, G. (2022). Prevalence and Risk Factors of Osteoporosis in Men with Chronic Obstructive Pulmonary Disease in Kars Province. Türk Osteoporoz Dergisi, Cilt: 25 - Sayı: 3, 99–104. https://ajindex.com/articles/639663

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Graat-Verboom L, Smeenk FW, van den Borne BE, Spruit MA, Donkers-van Rossum AB, Aarts RP et al. Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone 2012;50:1234-9
  2. Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int 2014;2014:965764
  3. Karapolat H, Eyigör S, Gürgün A, Kirazli Y. Erkek COPD Hastalarında Osteoporozun Değerlendirilmesi. Türk Osteoporoz Dergisi 2007;13:70-4
  4. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:64-75
  5. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014; 25:2359-81
  6. Ciric Z, Stankovic I, Pejcic T, Ristic L, Rancic M, Radovic M. Osteoporosis in patients with chronic obstructive pulmonary disease. Medical Archives 2012;66:385-7
  7. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55
  8. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41
  9. Okazaki R, Watanabe R, Inoue D. Osteoporosis Associated with Chronic Obstructive Pulmonary Disease. J Bone Metab 2016;23:111-20
  10. Kul A, Erdal A. Bone Mineral Density and Vitamin D Values in Behçet’s Disease. Turk J Osteoporos 2018;24:78-83
  11. Abbasi M, Zohal M, Atapour B, Yazdi Z. Prevalence of Osteoporosis and its Risk Factors in Men with COPD in Qazvin. Int J Chronic Dis 2016;2016:4038530
  12. Abu-Bakr SM, Eldin MMG, Hafez MR, Salem SM, Qandeel HT. Assessment of osteoporosis in patients with chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis 2014;63(3):597-602
  13. Biskobing DM. COPD and osteoporosis. Chest 2002;121:609-20
  14. Mansour OF, Bakr RM, Elwahsh RA, Zanfal AM. Osteoporosis in patients with chronic obstructive pulmonary disease. Menoufia Medical Journal 2015;28:521–524
  15. Sarıdoğan ME. Osteoporozda risk faktörlerinin değerlendirilmesi. In: Sarıdoğan ME, Gökçe-Kutsal Y, editörler. Osteoporoz tanı ve tedavi kılavuzu. İstanbul, 2005:5-25
  16. Taşoğlu Ö, Özdemir O, Kutsal YG. Osteoporozlu Hastalarda Gözardı Edilen Bir Risk Faktörü: Sigara Kullanımı. Turk J Osteoporos, 2011;